Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 15131 composition records across product categories including Personal care, Furniture and furnishings, Laboratory supplies.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of SODIUM CHLORIDE in our catalog (epa_cpdat).
Products
15,131
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 15131 composition records across product categories including Personal care, Furniture and furnishings, Laboratory supplies. EPA CPDat classifies this chemical for functional uses including Viscosity modifier, Surfactant (surface active agent), formulation.
US
FDA
Route: AURICULAR (OTIC); Dosage form: SOLUTION; Maximum daily exposure: 18 mg
US
FDA
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 18 mg
US
FDA
Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.9 %w/v
US
FDA
Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 3 mg
US
FDA
Route: DENTAL; Dosage form: INJECTION; Potency: 0.4 %w/v
US
FDA
Route: DENTAL; Dosage form: POWDER, DENTIFRICE; Potency: 0.03 mg/mg
US
FDA
Route: ENDOTRACHEAL; Dosage form: INJECTION; Maximum daily exposure: 68 mg
US
FDA
Route: ENDOTRACHEAL; Dosage form: POWDER, FOR SUSPENSION; Potency: 46.76 mg
US
FDA
Route: ENDOTRACHEAL; Dosage form: SUSPENSION; Potency: 7.6 mg
US
FDA
Route: EPIDURAL; Dosage form: INJECTION; Maximum daily exposure: 648 mg
US
FDA
Route: EPIDURAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 3535 mg
US
FDA
Route: EPIDURAL; Dosage form: INJECTION, SUSPENSION, LIPOSOMAL; Maximum daily exposure: 11 mg
US
FDA
Route: EPIDURAL; Dosage form: SOLUTION; Potency: 0.9 %w/v
US
FDA
Route: INFILTRATION; Dosage form: INJECTION; Maximum daily exposure: 648 mg
US
FDA
Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 3535 mg
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION; Maximum daily exposure: 278 mg
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 1.35 mg
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 278 mg
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION; Maximum daily exposure: 26 mg
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 45 mg
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 26 mg
US
FDA
Route: INTRABURSAL; Dosage form: INJECTION; Potency: 9 mg
US
FDA
Route: INTRACARDIAC; Dosage form: INJECTION; Maximum daily exposure: 70 mg
US
FDA
Route: INTRACAUDAL; Dosage form: INJECTION; Maximum daily exposure: 210 mg
US
FDA
Route: INTRACAUDAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 210 mg
US
FDA
Route: INTRACAVITARY; Dosage form: INJECTION; Potency: 0.82 %w/v
US
FDA
Route: INTRADERMAL; Dosage form: INJECTION; Potency: 7 mg
US
FDA
Route: INTRALESIONAL; Dosage form: INJECTION; Potency: 0.9 %w/v
US
FDA
Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 13 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 1486 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 226 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 360 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1486 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: 0.86 %w/v
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 26 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 24 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: LIQUID; Maximum daily exposure: 17 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: SOLUTION; Maximum daily exposure: 90 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: SUSPENSION; Potency: 9 mg
US
FDA
Route: INTRAOCULAR; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: 0.86 %w/v
US
FDA
Route: INTRAOCULAR; Dosage form: SOLUTION; Maximum daily exposure: 320 mg
US
FDA
Route: INTRAPERITONEAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 226 mg
US
FDA
Route: INTRAPERITONEAL; Dosage form: SOLUTION; Potency: 0.54 %w/v
US
FDA
Route: INTRAPLEURAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 226 mg
US
FDA
Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: 0.9 %w/v
US
FDA
Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 4 mg
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION; Maximum daily exposure: 9 mg
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 1.35 mg
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 131 mg
US
FDA
Route: INTRATUMOR; Dosage form: INJECTION; Potency: 1.2 %w/v
US
FDA
Route: INTRATYMPANIC; Dosage form: SUSPENSION; Maximum daily exposure: 2 mg
US
FDA
Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: 0.86 %w/v
US
FDA
Route: INTRAVASCULAR; Dosage form: SOLUTION; Potency: NA
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 28773 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: 0.62 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 2922 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 1800 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 2916 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: 0.86 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION; Potency: 0.9 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: LIQUID; Maximum daily exposure: 6320 mg
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 90 mg
US
FDA
Route: INTRAVESICAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 351 mg
US
FDA
Route: INTRAVITREAL; Dosage form: INJECTION; Potency: 10 %w/v
US
FDA
Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 6 mg
US
FDA
Route: IONTOPHORESIS; Dosage form: SOLUTION; Potency: 0.6 %w/v
US
FDA
Route: IONTOPHORESIS; Dosage form: SYSTEM; Potency: 3.1 mg
US
FDA
Route: NASAL; Dosage form: LIQUID; Potency: 7.4 mg/1ml
US
FDA
Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 30 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 36 mg
US
FDA
Route: OPHTHALMIC; Dosage form: DROPS; Potency: 0.08 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: GEL; Potency: 0.06 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: POWDER, FOR SOLUTION; Potency: 0.9 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 13 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 55 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 10 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 3 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 6 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 41 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 162 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 98 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 148 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 1126 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 40 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 231 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 20 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 54.7 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 97 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 335.1 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 100 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 10 mg
US
FDA
Route: PARENTERAL; Dosage form: INJECTION; Maximum daily exposure: 584 mg
US
FDA
Route: PARENTERAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 210 mg
US
FDA
Route: PERIDURAL; Dosage form: INJECTION; Potency: 8.07 mg
US
FDA
Route: PERINEURAL; Dosage form: INJECTION; Maximum daily exposure: 648 mg
US
FDA
Route: RECTAL; Dosage form: SUPPOSITORY; Maximum daily exposure: 140 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: INHALANT; Potency: 3 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Potency: NA
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Maximum daily exposure: 108 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SUSPENSION; Maximum daily exposure: 43 mg
US
FDA
Route: RETROBULBAR; Dosage form: INJECTION; Maximum daily exposure: 648 mg
US
FDA
Route: SOFT TISSUE; Dosage form: INJECTION; Potency: 0.9 %w/v
US
FDA
Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 26 mg
US
FDA
Route: SUBARACHNOID; Dosage form: INJECTION, SOLUTION; Potency: 0.9 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: IMPLANT; Potency: 77 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 1486 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 0.68 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: NA
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1486 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: 0.86 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: 0.8 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: LIQUID; Potency: 0.7 %w/v
US
FDA
Route: SUBCUTANEOUS; Dosage form: SOLUTION; Maximum daily exposure: 90 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: 0.8 %w/v
US
FDA
Route: SUBMUCOSAL; Dosage form: INJECTION; Maximum daily exposure: 17 mg
US
FDA
Route: SUBMUCOSAL; Dosage form: INJECTION, SOLUTION; Potency: 16 %w/v
US
FDA
Route: TOPICAL; Dosage form: LOTION; Potency: 0.3 %w/v
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO; Maximum daily exposure: 150 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 210 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION/ DROPS; Potency: 0.86 %w/v
US
FDA
Route: TOPICAL; Dosage form: SUSPENSION; Potency: 0.32 %w/v
US
FDA
Route: TOPICAL; Dosage form: SUSPENSION/ DROPS; Potency: 0.23 %w/v
US
FDA
FDA NDC lists this ingredient in 963 active drug products and 1028 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
USDA FoodData Central
Observed in 6 USDA branded foods including 1 LITER BOTTLE VICHY WATER, 1.5OZ LITEHOUSE BALSAMIC VINAIGRETTE, 1.5OZ LITEHOUSE CHUNKY BLUE CHEESE DRESSING.